Healthcare stocks are narrowly mixed, with the NYSE Healthcare
Sector Index ahead about 0.3% while shares of healthcare companies
in the S&P 500 are down 0.3% as a group this afternoon.
In company news, ZELTIQ Aesthetics Inc. (
) is down 4.4% at $14.67, trading underwater throughout the session
after last night disclosing plans to sell 3.5 million shares of its
common stock now owned by Advanced Technology Ventures, an earlier
investor in the medical device company.
The underwritten offering will also include Aisling Capital and
Venrock Associates each selling 500,000 shares, according to a
preliminary prospectus for the deal filed with the U.S. Securities
and Exchange Commission.
ZLTQ - which saw its stock last week surge to its best price
levels since its initial public offering just over two years ago
following strong Q3 earnings and forward guidance - will not
receive any proceeds from the offering.
In other sector news,
(+) OXGN, (+74.4%) Said its Zybrestat drug candidate showed
statistically significant differences between the treatment and
control arms in pre-clinical testing using a model of pancreatic
(-) NAVB, (-17.7%) Q3 loss of $0.09 per share is $0.01 wider
than the Capital IQ consensus. Reports $400 mln in quarterly
revenue, also lagging expectations by around $70,000.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.